What Is Aldolase B?

Aldolase B is the enzyme that handles the second major step of fructose metabolism. After ketohexokinase (KHK) uses ATP to convert fructose into fructose-1-phosphate, Aldolase B splits that molecule into glyceraldehyde and dihydroxyacetone phosphate. Those smaller molecules can then enter pathways used to make energy, glucose, glycogen or fat.

The enzyme is especially important in the liver, kidney and small intestine—the same tissues that carry much of the body's fructose-processing burden.

The Hereditary Fructose Intolerance Experiment

Hereditary fructose intolerance (HFI) is caused by damaging variants in the ALDOB gene. Without enough functional Aldolase B, fructose-1-phosphate accumulates after exposure to fructose, sucrose or sorbitol.

The result is a striking metabolic cascade: phosphate becomes trapped, ATP regeneration is impaired, glycogen breakdown and gluconeogenesis are inhibited, and uric acid can rise. This can produce severe hypoglycemia and liver or kidney injury. HFI is rare, but it functions as a powerful natural experiment showing what happens when fructose enters the pathway and its first committed product cannot be cleared.

What Aldolase B Reveals About Metabolic Flux

Aldolase B changes the question from simply how much fructose is present? to how quickly is fructose entering the pathway, and how efficiently can the pathway process what follows?

HFI is not the same as ordinary metabolic dysfunction, and healthy people should not be described as partially Aldolase-B deficient without evidence. The larger lesson is still important: metabolic pathways depend on balance. A rapid upstream reaction can change cellular energy before downstream steps restore equilibrium.

This helps explain why ATP, phosphate and uric acid are central to the fructose story—and why the first committed step deserves close attention.

The Connection to Ketohexokinase (KHK)

KHK acts first. It consumes ATP and creates fructose-1-phosphate. Aldolase B acts next and clears that product. When Aldolase B is absent, the consequences of continued KHK activity become unmistakable.

That relationship makes upstream control scientifically compelling. It does not mean that inhibiting KHK treats HFI, nor does it establish that any supplement changes Aldolase B activity. It does show why researchers increasingly study KHK as a metabolic control point rather than viewing fructose as just another source of calories.

LIV3's working model begins there: if the speed of fructose commitment matters, influencing the entry step may add a useful layer to dietary and metabolic strategies.

Sources and Clinical Note

IUBMB Enzyme Nomenclature: EC 4.1.2.13
GeneReviews: Hereditary Fructose Intolerance
Simons et al. Recent advances in hereditary fructose intolerance

Important: suspected HFI requires medical evaluation. A fructose challenge should not be used for self-testing because it can be dangerous. SugarShield is a dietary supplement, not a treatment for HFI or Aldolase B deficiency, and it has not been shown to change Aldolase B activity. This page is educational and is not medical advice.